Ra Capital Management, L.P. Relay Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $3.05 Million - $5.29 Million	168,563 Added 30.7%	717,618 $16.1 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $14.3 Million - $20.3 Million	549,055 New	549,055 $16.9 Million
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $27.5 Million - $38.2 Million	-1,000,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $32.8 Million - $45.1 Million	1,000,000 New	1,000,000 $42.6 Million

183

127M

1.7K

18K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $786M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.